Sriram Ryali

Insider Reports History

Location
Palo Alto, CA
Signature
/s/ Barbara G. McClung, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sriram Ryali:

Company Role Class Num Shares Value Price $ Report Date Ownership
CODEXIS, INC. Chief Financial Officer Common Stock 175,791 $370,638 $2.11 01 Jan 2024 Direct
Caribou Biosciences, Inc. Chief Financial Officer Common Stock 17,360 $24,651 $1.42 29 Jan 2025 Direct
Eiger BioPharmaceuticals, Inc. Chief Financial Officer Common Stock 41,566 $12,374 $0.2977 14 Mar 2022 Direct
CODEXIS, INC. Chief Financial Officer Stock Option (Right to Buy) 314,125 01 Jan 2024 Direct
Caribou Biosciences, Inc. Chief Financial Officer Option to purchase Common Stock 300,000 10 Jan 2025 Direct
Eiger BioPharmaceuticals, Inc. Chief Financial Officer Stock Option (Right to Buy) 143,000 11 Mar 2022 Direct

Insider Reports Filed by Sriram Ryali

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRBU Caribou Biosciences, Inc. 29 Jan 2025 1 +$24,651 4 Chief Financial Officer 30 Jan 2025, 16:02
CRBU Caribou Biosciences, Inc. 10 Jan 2025 1 $0 4 Chief Financial Officer 10 Jan 2025, 17:06
CRBU Caribou Biosciences, Inc. 02 Jan 2025 0 $0 3 Chief Financial Officer 10 Jan 2025, 16:55
CDXS CODEXIS, INC. 01 Jan 2024 2 $0 4 Chief Financial Officer 02 Jan 2024, 21:24
CDXS CODEXIS, INC. 08 Sep 2023 1 +$19,856 4 Chief Financial Officer 12 Sep 2023, 16:07
CDXS CODEXIS, INC. 10 Feb 2023 2 $0 4 Chief Financial Officer 14 Feb 2023, 15:11
CDXS CODEXIS, INC. 23 Jan 2023 0 $0 3 Chief Financial Officer 25 Jan 2023, 15:29
/report/000156761922006948-ryali-sriram-2022-03-14 Eiger BioPharmaceuticals, Inc. 14 Mar 2022 1 -$12,683 4 Chief Financial Officer 14 Mar 2022, 21:22
/report/000114036122009262-ryali-sriram-2022-03-11 Eiger BioPharmaceuticals, Inc. 11 Mar 2022 2 $0 4 Chief Financial Officer 11 Mar 2022, 20:06
/report/000156761921014218-ryali-sriram-2021-07-29 Eiger BioPharmaceuticals, Inc. 29 Jul 2021 1 $0 4 Chief Financial Officer 30 Jul 2021, 16:26
/report/000120919121031905-ryali-sriram-2021-05-10 Eiger BioPharmaceuticals, Inc. 10 May 2021 1 $0 4 Chief Financial Officer 11 May 2021, 20:32